World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
Abbott to Pay $1.6 Billion
Keywords:
Tags: Pharmaceutical,
Abbott is placed on a five year probationary period by the U.S. Justice Department. This comes after the $1.6 billion legal settlement for aggressive marketing practices to sell the drug Depakote in nursing homes.
Abbott Labs performance
10/19/2006
Grouped Articles
Abbott Labs Spices Up Its Drug Portfolio
Wall Street Journal 05/22/2010
Abbott Labs to Buy Indian Drug Maker
Wall Street Journal 05/22/2010
Abbott to Split Into Two Companies
Wall Street Journal 10/20/2011
Abbott Labs Licenses Molecules from Reata
Wall Street Journal 12/12/2011
Abbott Looks to Consumer for Growth
Wall Street Journal 05/03/2012
Abbott Is Buoyed By Arthritis Drug, Guidant's Stents - WSJ.com
Wall Street Journal 10/19/2006
Abbott Labs product quality and safety.
09/23/2010
Grouped Articles
Beetles Prompt Recall of Similac Baby Formula
Wall Street Journal 09/23/2010
Abbott Looks to Consumer for Growth
Wall Street Journal 05/03/2012
Abbott Laboratories to pay $1.6 billion over illegal marketing of Depakote - The Washington Post
Washington Post 05/08/2012
Abbott to Pay $1.6 Billion Over Illegal Marketing
New York Times 05/07/2012
Wall Street Journal 05/08/2012
Large legal settlements in the pharmaceutical industry.
10/25/2006
The settlements also involve drug pricing and marketing.
Grouped Articles
Drug Firms Curb Ties to Doctors
Wall Street Journal 12/18/2013
In Guilty Plea, OxyContin Maker to Pay $600 Million
New York Times 05/10/2007
Glaxo Sues Abbott Labs Over AIDS Drug Pricing
Wall Street Journal 11/09/2007
Drug Companies Face Political, Scientific Attacks
Wall Street Journal 01/23/2008
Drug Industry to Announce Revised Code on Marketing
New York Times 07/10/2008
Drug Approval Is Not a Shield From Lawsuits, Justices Rule
New York Times 03/05/2009
Safety and marketing issues raised about drugs generating large sales for pharmaceutical companies.
10/25/2006
Grouped Articles
Drug Firms Curb Ties to Doctors
Wall Street Journal 12/18/2013
Medical Journal Spikes Article On Industry Ties Of Kidney Group - WSJ.com
Wall Street Journal 12/26/2006
Amgen's Star Fades Amid Safety Questions
Wall Street Journal 04/10/2007
Suit Details How J&J Pushed Sales of Procrit
Wall Street Journal 05/10/2007
BusinessWeek 05/21/2007
Sequel for Vioxx Critic: Attack on Diabetes Pill
Wall Street Journal 05/22/2007
Abbott Labs management
05/22/2010
Grouped Articles
Abbott Labs to Buy Indian Drug Maker
Wall Street Journal 05/22/2010
Abbott to Split Into Two Companies
Wall Street Journal 10/20/2011
Abbott Looks to Consumer for Growth
Wall Street Journal 05/03/2012
Abbott to Pay $1.6 Billion Over Illegal Marketing
New York Times 05/07/2012
Wall Street Journal 05/08/2012
Abbott Labs's $1.6 billion legal settlement for aggressive marketing of neurologic drug Depakote in U.S. nursing homes
04/10/2007
Grouped Articles
Abbott Laboratories to pay $1.6 billion over illegal marketing of Depakote - The Washington Post
Washington Post 05/08/2012
Abbott to Pay $1.6 Billion Over Illegal Marketing
New York Times 05/07/2012
Wall Street Journal 05/08/2012
Anemia drug made billions, but at what cost? - The Washington Post
Washington Post 07/20/2012
FDA Cancer Czar Stirs Debate On Agency's Role
Wall Street Journal 03/12/2008
Stronger Warnings on 3 Drugs for Anemia
New York Times 11/09/2007
Slimming down marketing and sales at American and European pharmaceutical companies.
10/25/2006
American and European drug companies are slimming down marketing and sales as the old marketing practices are not working, and new strategies are taking their place.
Grouped Articles
Drug Firms Curb Ties to Doctors
Wall Street Journal 12/18/2013
Wall Street Journal 01/16/2007
Drug Companies Face Political, Scientific Attacks
Wall Street Journal 01/23/2008
CEO Gambles on a Novartis Makeover
Wall Street Journal 05/20/2008
Drug Industry to Announce Revised Code on Marketing
New York Times 07/10/2008
Wall Street Journal 10/21/2008
The U.S. pharmaceutical market.
10/29/2008
Grouped Articles
Outlook Is Cut for U.S. Drug Sales
Wall Street Journal 10/29/2008
Wall Street Journal 05/08/2012
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us